SCHEMBL3414271

SCHEMBL3414271

O=c1[nH]n2c(=O)c3c([nH]c2c1Nc1ccc(F)cc1)CCCC3

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.46
TDP1 Q9NUW8 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
POLB P06746 7/20 0.44
LMNA P02545 5/20 0.44
HTT P42858 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HPGD P15428 6/20 0.43
KDM4E B2RXH2 3/20 0.43
CRHBP P24387 2/20 0.43
CRHR2 Q13324 2/20 0.43
BLM P54132 2/20 0.43
CTDSP1 Q9GZU7 2/20 0.43
GAA P10253 2/20 0.43
ALPL P05186 1/20 0.43
ALPI P09923 1/20 0.43
ALPG P10696 1/20 0.43
HKDC1 Q2TB90 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3413627 0.73 MAPT (0.46) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3411555 0.73 ALDH1A1 (0.46) MAPTL3MBTL1MEN1KMT2APOLB
SCHEMBL3405825 0.72 MAPT (0.55) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3411702 0.71 CYP1A2 (0.53) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3409206 0.70 MAPT (0.47) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3409245 0.69 MEN1 (0.50) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3411760 0.69 MAPT (0.59) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3411499 0.68 MAPT (0.47) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3410031 0.68 MAPT (0.52) MAPTTDP1L3MBTL1MEN1KMT2A
SCHEMBL3407279 0.67 MAPT (0.48) MAPTTDP1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP claimed
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP disclosed